156 related articles for article (PubMed ID: 27312991)
1. Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology.
Kolisnyk B; Al-Onaizi M; Soreq L; Barbash S; Bekenstein U; Haberman N; Hanin G; Kish MT; Souza da Silva J; Fahnestock M; Ule J; Soreq H; Prado VF; Prado MAM
Cereb Cortex; 2017 Jul; 27(7):3553-3567. PubMed ID: 27312991
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic Regulation of hnRNPA2/B1 Translation by M1 Muscarinic Receptors.
Kolisnyk B; Al-Onaizi MA; Xu J; Parfitt GM; Ostapchenko VG; Hanin G; Soreq H; Prado MA; Prado VF
J Neurosci; 2016 Jun; 36(23):6287-96. PubMed ID: 27277805
[TBL] [Abstract][Full Text] [Related]
3. Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.
Kolisnyk B; Al-Onaizi MA; Hirata PH; Guzman MS; Nikolova S; Barbash S; Soreq H; Bartha R; Prado MA; Prado VF
J Neurosci; 2013 Sep; 33(37):14908-20. PubMed ID: 24027290
[TBL] [Abstract][Full Text] [Related]
4. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
[TBL] [Abstract][Full Text] [Related]
6. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
7. SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1.
Kurkinen KM; Marttinen M; Turner L; Natunen T; Mäkinen P; Haapalinna F; Sarajärvi T; Gabbouj S; Kurki M; Paananen J; Koivisto AM; Rauramaa T; Leinonen V; Tanila H; Soininen H; Lucas FR; Haapasalo A; Hiltunen M
J Cell Sci; 2016 Jun; 129(11):2224-38. PubMed ID: 27084579
[TBL] [Abstract][Full Text] [Related]
8. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
9. GRK5 dysfunction accelerates tau hyperphosphorylation in APP (swe) mice through impaired cholinergic activity.
Zhang Y; Chen L; Shen G; Zhao Q; Shangguan L; He M
Neuroreport; 2014 May; 25(7):542-7. PubMed ID: 24598771
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil Decreases BACE1 and Cathepsin B Levels and Reduces APP Amyloidogenic Processing in the SAMP8 Mouse.
Orejana L; Barros-Miñones L; Jordan J; Cedazo-Minguez A; Tordera RM; Aguirre N; Puerta E
J Gerontol A Biol Sci Med Sci; 2015 Jun; 70(6):675-85. PubMed ID: 25063079
[TBL] [Abstract][Full Text] [Related]
11. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
12. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
[TBL] [Abstract][Full Text] [Related]
13. BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
Yu CJ; Liu W; Chen HY; Wang L; Zhang ZR
Cell Biochem Funct; 2014 Oct; 32(7):590-6. PubMed ID: 25230339
[TBL] [Abstract][Full Text] [Related]
14. Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease.
Peters F; Salihoglu H; Pratsch K; Herzog E; Pigoni M; Sgobio C; Lichtenthaler SF; Neumann U; Herms J
EMBO J; 2019 Dec; 38(23):e102345. PubMed ID: 31701556
[TBL] [Abstract][Full Text] [Related]
15. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
Devi L; Ohno M
Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
[TBL] [Abstract][Full Text] [Related]
16. Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice.
Gerenu G; Dobarro M; Ramirez MJ; Gil-Bea FJ
Biochim Biophys Acta; 2013 Jun; 1832(6):837-47. PubMed ID: 23474306
[TBL] [Abstract][Full Text] [Related]
17. NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models.
Bahn G; Park JS; Yun UJ; Lee YJ; Choi Y; Park JS; Baek SH; Choi BY; Cho YS; Kim HK; Han J; Sul JH; Baik SH; Lim J; Wakabayashi N; Bae SH; Han JW; Arumugam TV; Mattson MP; Jo DG
Proc Natl Acad Sci U S A; 2019 Jun; 116(25):12516-12523. PubMed ID: 31164420
[TBL] [Abstract][Full Text] [Related]
18. Insulin-Like Growth Factor-1 Alleviates Expression of Aβ
Song F; Liu T; Meng S; Li F; Zhang Y; Jiang L
J Mol Neurosci; 2018 Dec; 66(4):595-603. PubMed ID: 30414017
[TBL] [Abstract][Full Text] [Related]
19. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
Ji Y; Wang D; Zhang B; Lu H
J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
[TBL] [Abstract][Full Text] [Related]
20. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
